136 related articles for article (PubMed ID: 32108191)
1. Protein corona formation and its influence on biomimetic magnetite nanoparticles.
Peigneux A; Glitscher EA; Charbaji R; Weise C; Wedepohl S; Calderón M; Jimenez-Lopez C; Hedtrich S
J Mater Chem B; 2020 Jun; 8(22):4870-4882. PubMed ID: 32108191
[TBL] [Abstract][Full Text] [Related]
2. pH-Dependent Adsorption Release of Doxorubicin on MamC-Biomimetic Magnetite Nanoparticles.
García Rubia G; Peigneux A; Jabalera Y; Puerma J; Oltolina F; Elert K; Colangelo D; Gómez Morales J; Prat M; Jimenez-Lopez C
Langmuir; 2018 Nov; 34(45):13713-13724. PubMed ID: 30394747
[TBL] [Abstract][Full Text] [Related]
3. Magnetoliposomes of mixed biomimetic and inorganic magnetic nanoparticles as enhanced hyperthermia agents.
Jabalera Y; Fernández-Vivas A; Iglesias GR; Delgado ÁV; Jimenez-Lopez C
Colloids Surf B Biointerfaces; 2019 Nov; 183():110435. PubMed ID: 31430636
[TBL] [Abstract][Full Text] [Related]
4. mAb-Functionalized Biomimetic MamC-Mediated-Magnetoliposomes as Drug Delivery Systems for Cancer Therapy.
Oltolina F; Santaella Escolano MDC; Jabalera Y; Prat M; Jimenez Lopez C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762260
[TBL] [Abstract][Full Text] [Related]
5. Tuning properties of biomimetic magnetic nanoparticles by combining magnetosome associated proteins.
Peigneux A; Jabalera Y; Vivas MAF; Casares S; Azuaga AI; Jimenez-Lopez C
Sci Rep; 2019 Jun; 9(1):8804. PubMed ID: 31217514
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic Magnetite Nanoparticles as Targeted Drug Nanocarriers and Mediators of Hyperthermia in an Experimental Cancer Model.
Oltolina F; Peigneux A; Colangelo D; Clemente N; D'Urso A; Valente G; Iglesias GR; Jiménez-Lopez C; Prat M
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32916816
[TBL] [Abstract][Full Text] [Related]
7. The importance of cell uptake in photothermal treatments mediated by biomimetic magnetic nanoparticles.
Lázaro M; Lupiáñez P; Sola-Leyva A; Pozo-Gualda T; Oltolina F; Jimenez-Carretero M; Jimenez-Lopez C; Carrasco-Jiménez MP; Iglesias GR
Colloids Surf B Biointerfaces; 2024 Feb; 234():113722. PubMed ID: 38160473
[TBL] [Abstract][Full Text] [Related]
8. Improving the Cellular Uptake of Biomimetic Magnetic Nanoparticles.
Vurro F; Jabalera Y; Mannucci S; Glorani G; Sola-Leyva A; Gerosa M; Romeo A; Romanelli MG; Malatesta M; Calderan L; Iglesias GR; Carrasco-Jiménez MP; Jimenez-Lopez C; Perduca M
Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33803544
[No Abstract] [Full Text] [Related]
9. Enhanced Cytotoxic Effect of TAT-PLGA-Embedded DOXO Carried by Biomimetic Magnetic Nanoparticles upon Combination with Magnetic Hyperthermia and Photothermia.
Jabalera Y; Sola-Leyva A; Gaglio SC; Carrasco-Jiménez MP; Iglesias GR; Perduca M; Jimenez-Lopez C
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452129
[TBL] [Abstract][Full Text] [Related]
10. Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake.
Di Silvio D; Rigby N; Bajka B; Mackie A; Baldelli Bombelli F
Int J Biochem Cell Biol; 2016 Jun; 75():212-22. PubMed ID: 26520468
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content.
Rodríguez-Ruiz I; Delgado-López JM; Durán-Olivencia MA; Iafisco M; Tampieri A; Colangelo D; Prat M; Gómez-Morales J
Langmuir; 2013 Jul; 29(26):8213-21. PubMed ID: 23735159
[TBL] [Abstract][Full Text] [Related]
12. Size control of in vitro synthesized magnetite crystals by the MamC protein of Magnetococcus marinus strain MC-1.
Valverde-Tercedor C; Montalbán-López M; Perez-Gonzalez T; Sanchez-Quesada MS; Prozorov T; Pineda-Molina E; Fernandez-Vivas MA; Rodriguez-Navarro AB; Trubitsyn D; Bazylinski DA; Jimenez-Lopez C
Appl Microbiol Biotechnol; 2015 Jun; 99(12):5109-21. PubMed ID: 25874532
[TBL] [Abstract][Full Text] [Related]
13. Investigation of novel superparamagnetic Ni
Qasim M; Asghar K; Dharmapuri G; Das D
Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
[TBL] [Abstract][Full Text] [Related]
14. Mechanochemically activated doxorubicin nanoparticles in combination with 40 MHz frequency irradiation on A-549 lung carcinoma cells.
Orel VE; Kudryavets YI; Satz S; Bezdenezhnih NA; Danko ML; Khranovskaya NN; Romanov AV; Dzyatkovskaya NN; Burlaka AP
Drug Deliv; 2005; 12(3):171-8. PubMed ID: 16025847
[TBL] [Abstract][Full Text] [Related]
15. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles.
Yallapu MM; Chauhan N; Othman SF; Khalilzad-Sharghi V; Ebeling MC; Khan S; Jaggi M; Chauhan SC
Biomaterials; 2015 Apr; 46():1-12. PubMed ID: 25678111
[TBL] [Abstract][Full Text] [Related]
16. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
Rajkumar S; Prabaharan M
Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
[TBL] [Abstract][Full Text] [Related]
17. Folic acid conjugated Fe
Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
[TBL] [Abstract][Full Text] [Related]
18. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation.
Chen W; Cheng CA; Zink JI
ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500
[TBL] [Abstract][Full Text] [Related]
19. Can Be a Bimetal Oxide ZnO-MgO Nanoparticles Anticancer Drug Carrier and Deliver? Doxorubicin Adsorption/Release Study.
Kumar R; Gokulakrishnan N; Kumar R; Krishna VM; Saravanan A; Supriya S; Somanathan T
J Nanosci Nanotechnol; 2015 Feb; 15(2):1543-53. PubMed ID: 26353689
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
